Market Currents
Bio-Reference Laboratories (BRLI +9.1%) pops after beating FQ1 estimates earlier. Revenue jumped...
-
Thursday, March 1, 2012, 11:25 AM ETBio-Reference Laboratories (BRLI +9.1%) pops after beating FQ1 estimates earlier. Revenue jumped 23% Y/Y on double digit sales growth as the clinical-testing company's patient count has risen and its share of complex, non-routine testing services continues to grow.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
